Sargramostim Injection Clinical Trials

• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
  Lymphoma
  
• Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
  ClinicalTrials.gov Identifier: NCT00003315 - Active, not recruiting
  Infection
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
  ClinicalTrials.gov Identifier: NCT00004256 - Active, not recruiting
  Laryngeal Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002950 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
  ClinicalTrials.gov Identifier: NCT00017121 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma; lung metastases
  
• Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00003897 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00071955 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00027911 - Active, not recruiting
  adult soft tissue sarcoma; adult synovial sarcoma
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00037037 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002780 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00005948 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia
  
• Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
  ClinicalTrials.gov Identifier: NCT00006483 - Active, not recruiting
  Stage IV Renal Cell Cancer; lung metastases; recurrent renal cell cancer
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089193 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00012376 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Rituximab, Autologous Vaccine Therapy, and Sargramostim in Treating Patients With Recurrent or Refractory Follicular B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00060164 - Active, not recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma
  
• Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
  ClinicalTrials.gov Identifier: NCT00069940 - Active, not recruiting
  Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00066365 - Recruiting
  metastatic osteosarcoma; recurrent osteosarcoma; lung metastases
  
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
  Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
  
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
  ClinicalTrials.gov Identifier: NCT00089063 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Interferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003561 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00017290 - Active, not recruiting
  stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
  
• Sargramostim and/or Montanide ISA-51 in Treating Patients With Stage I or Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00089232 - Recruiting
  Recurrent Melanoma; stage I melanoma; stage II melanoma
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation Followed by Interleukin-2 and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003199 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer; inflammatory breast cancer
  
• Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00020254 - Active, not recruiting
  Prostate Cancer
  
• Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002778 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079157 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004036 - Active, not recruiting
  Cancer
  
• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004198 - Active, not recruiting
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn’s Disease Who Have Previously Responded to Treatment With Sargramostim
  ClinicalTrials.gov Identifier: NCT00206713 - Completed
  Crohn Disease
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003397 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
  ClinicalTrials.gov Identifier: NCT00003125 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage III pancreatic cancer; stage IV breast cancer; stage IIIA non-small cell lung cancer; ...
  
• Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00072358 - Recruiting
  disseminated neuroblastoma; localized unresectable neuroblastoma; recurrent neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• DTPACE followed by Tandem Transplant with MEL 200 versus MEL/DTPACE Hybrid and DTPACE Consolidation
  ClinicalTrials.gov Identifier: NCT00083915 - Active, not recruiting
  Multiple Myeloma
  
• Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00026312 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Docetaxel and Vinorelbine Plus Sargramostim in Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00256282 - Recruiting
  Metastatic Melanoma
  
• Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00003274 - Active, not recruiting
  stage II melanoma
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00023777 - Active, not recruiting
  Myeloid Leukemia
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002461 - Active, not recruiting
  Lymphocytic Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
  
• Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer
  ClinicalTrials.gov Identifier: NCT00014573 - Active, not recruiting
  Brain Tumor
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma
  ClinicalTrials.gov Identifier: NCT00510471 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• Vaccine Therapy and Sargramostim in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00091000 - Recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; unspecified adult solid tumor, protocol specific
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003269 - Active, not recruiting
  Lung Cancer; Ovarian Cancer; Lymphoma; Leukemia; Breast Cancer
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003972 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
  ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00025363 - Active, not recruiting
  recurrent childhood rhabdomyosarcoma; embryonal childhood rhabdomyosarcoma; alveolar childhood rhabdomyosarcoma; ...
  
• Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-Cell Lymphoma, a Form of Non-Hodgkin’s Lymphoma
  ClinicalTrials.gov Identifier: NCT00308087 - Recruiting
  Lymphoma, Follicular
  
• Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003181 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• A Phase II Trial of Docetaxel/Prednisone in Combination With Sargramostim as Treatment for Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00313482 - Recruiting
  Hormone Refractory Prostate Cancer
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• FCR Plus Sargramostim (GM-CSF) as Frontline Therapy in Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00381004 - Recruiting
  Chronic Lymphocytic Leukemia; Leukemia
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00004184 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00004141 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms